FTC & Supreme Greens
This article was originally published in The Tan Sheet
Executive Summary
Direct Marketing Concepts, ITV Direct and Donald Barrett are barred from claiming that dietary supplement Supreme Greens with MSM treats, cures or prevents cancer, diabetes, arthritis and heart disease under a preliminary injunction obtained by the Federal Trade Commission announced July 2. The defendants also must prominently display disclaimers that infomercials aired to promote the product are paid advertisements, and may not sell or distribute products or services by means of a continuity program without informed consent from the consumer, according to the ruling. FTC filed charges in June 2004 alleging the defendants had deceptively marketed Supreme Greens through an infomercial, failed to disclose the program was a paid promotion and charged credit cards for automatic product shipments without consent...
You may also be interested in...
Supreme Greens settlement
Supreme Greens developer Alejandro Guerrero and his company Health Solutions will pay $65,000 or transfer to FTC the title to Guerrero's 2004 Cadillac Escalade for allegedly claiming that Supreme Greens could prevent, treat or cure cancer, heart disease, arthritis and diabetes, the commission announces Oct. 6. The herbal supplement also was promoted for substantial weight loss. Healthy Solutions and two other individuals will also pay a combined total of $15,000. The settlement has two avalanche clauses for a $4.17 mil. total. FTC filed the complaint in June 2004, litigation is still pending against ITV Direct, Direct Marketing Concepts and other others (1"The Tan Sheet" July 5, 2004, In Brief) ...
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.